Growth Metrics

Iradimed (IRMD) Shares Repurchased (2016 - 2017)

Iradimed (IRMD) reported Shares Repurchased of -$1.0 for Q4 2017, down 100.0% on a QoQ basis from $265349.0 in Q3 2017.

Iradimed (IRMD) has 2 years of Shares Repurchased data on file, last reported at -$1.0 in Q4 2017.

  • Quarterly Shares Repurchased changed N/A year-over-year to -$1.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $265348.0 (down 97.34% YoY) and the FY2017 annual result came in at $1.8 million, down 81.76% from the prior year.
  • Shares Repurchased fell to -$1.0 in Q4 2017 per IRMD's latest filing, from $265349.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $5.5 million in Q1 2016 and bottomed at -$1.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 180.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 105.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 421.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 100.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 74.30 Mn
10 Iradimed 1.17 Bn 1.11 Bn 16.81 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2017 -1.00
Dec 31, 2017 -1.00
Sep 30, 2017 265,349.00
Sep 30, 2017 265,349.00
Jun 30, 2016 4.46 Mn
Jun 30, 2016 4.46 Mn
Mar 31, 2016 5.51 Mn
Mar 31, 2016 5.51 Mn